Categories AlphaGraphs, Earnings, Health Care
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company’s net loss narrowed sharply from the prior-year period.
Third-quarter revenues declined 6% year-over-year to $2.40 million. Despite that, Trxade’s net loss narrowed to $0.50 million or $0.06 per share in the September quarter from $1.30 million or $0.16 per share in the comparable period of fiscal 2021.
“These first nine months of 2022 have been an exciting and challenging time for TRxADE. We continue to focus the Company’s strategic plans and partnerships working towards creating sustainable value for our stockholders. I am pleased with the growth we have experienced in our TRxADE platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Check this space to read management/analysts’ comments on Trxade’s Q2 2022 results
Shares of Trxade traded slightly lower early Tuesday, after closing the previous session lower. In the past six months, the stock experienced volatility.
Prior Performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on